Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Hakala M, Järvinen P, Ahonen J, Forsberg S, Leirisalo-Repo M; FIN-RACo Trial Group. Puolakka K, et al. Among authors: hakala m. Arthritis Rheum. 2005 Jan;52(1):36-41. doi: 10.1002/art.20716. Arthritis Rheum. 2005. PMID: 15641055 Free article. Clinical Trial.
Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Julkunen H, Luukkainen R, Vuori K, Paimela L, Blåfield H, Hakala M, Leirisalo-Repo M. Puolakka K, et al. Among authors: hakala m. Arthritis Rheum. 2004 Jan;50(1):55-62. doi: 10.1002/art.11436. Arthritis Rheum. 2004. PMID: 14730599 Free article. Clinical Trial.
Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study.
Korpela M, Laasonen L, Hannonen P, Kautiainen H, Leirisalo-Repo M, Hakala M, Paimela L, Blåfield H, Puolakka K, Möttönen T; FIN-RACo Trial Group. Korpela M, et al. Among authors: hakala m. Arthritis Rheum. 2004 Jul;50(7):2072-81. doi: 10.1002/art.20351. Arthritis Rheum. 2004. PMID: 15248204 Free article. Clinical Trial.
The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
Rantalaiho V, Korpela M, Hannonen P, Kautiainen H, Järvenpää S, Leirisalo-Repo M, Hakala M, Puolakka K, Julkunen H, Luosujärvi R, Möttönen T; FIN-RACo Trial Group. Rantalaiho V, et al. Among authors: hakala m. Arthritis Rheum. 2009 May;60(5):1222-31. doi: 10.1002/art.24447. Arthritis Rheum. 2009. PMID: 19404945 Free article. Clinical Trial.
Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group.
Möttönen T, Hannonen P, Leirisalo-Repo M, Nissilä M, Kautiainen H, Korpela M, Laasonen L, Julkunen H, Luukkainen R, Vuori K, Paimela L, Blåfield H, Hakala M, Ilva K, Yli-Kerttula U, Puolakka K, Järvinen P, Hakola M, Piirainen H, Ahonen J, Pälvimäki I, Forsberg S, Koota K, Friman C. Möttönen T, et al. Among authors: hakala m. Lancet. 1999 May 8;353(9164):1568-73. doi: 10.1016/s0140-6736(98)08513-4. Lancet. 1999. PMID: 10334255 Clinical Trial.
Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study.
Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Hakala M, Korpela M, Ilva K, Yli-Kerttula U, Piirainen H, Leirisalo-Repo M; FIN-RACo Trial Troup. Puolakka K, et al. Among authors: hakala m. Ann Rheum Dis. 2005 Jan;64(1):130-3. doi: 10.1136/ard.2003.019034. Ann Rheum Dis. 2005. PMID: 15608311 Free PMC article. Clinical Trial.
Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial.
Puolakka K, Kautiainen H, Pekurinen M, Möttönen T, Hannonen P, Korpela M, Hakala M, Arkela-Kautiainen M, Luukkainen R, Leirisalo-Repo M; FIN-RACo Trial Group. Puolakka K, et al. Among authors: hakala m. Ann Rheum Dis. 2006 Jul;65(7):899-904. doi: 10.1136/ard.2005.045807. Epub 2005 Nov 16. Ann Rheum Dis. 2006. PMID: 16291811 Free PMC article.
290 results